T36.AX5D is a new billable/specific and POA-exempt diagnosis code introduced in the 2026 ICD-10-CM used to classify the following condition: Adverse effect of fluoroquinolone antibiotics, subsequent encounter.
Versions
2026
New code
2026
ICD-10-CM
Diagnosis
Code
ICD-10-CM
Diagnosis
Code
T36.AX5D Adverse effect of fluoroquinolone antibiotics, subsequent encounter
- Billable
- POA Exempt
- 2026–2026